<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> and inflammatory damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Celastrol has been proved to elicit a vanity of biological effects through its anti-oxidant, anti-inflammatory properties in the treatment of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, and <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, little is known regarding the effect of celastrol in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This study investigated the potential protective effects of celastrol and underlying mechanisms in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We used a permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pMCAO) model and administered celastrol intraperitoneally immediately after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>At 24h after <z:hpo ids='HP_0001297'>stroke</z:hpo>, we found that celastrol dramatically reduced neurological deficit, brain water content and <z:mpath ids='MPATH_124'>infarct</z:mpath> sizes, and downregulated the expression of p-JNK, p-c-Jun and NF-κB </plain></SENT>
<SENT sid="6" pm="."><plain>The results indicated that celastrol may have the possibility of protective effect against ischemic injury, and this effect may be through downregulation of the expression of p-JNK, p-c-Jun and NF-κB </plain></SENT>
</text></document>